 |
|
|
|
 |
|||
Earlier today, Fresenius SE (FRE3:GY) announced that it was buying APP Pharmaceuticals (APPX) for $4.6 billion, or around $23 a share. The deal represented a substantial premium — just shy of 30% — over where APP’s shares closed on Thursday, before the markets closed for the July 4 holiday. But what’s really interesting is this [...]
As anyone who reads SEC filings regularly knows, today’s a big deadline for companies on a calendar year, which means that filings are backed up like planes at LaGuardia. All of us here at footnoted are finding lots of interesting things and while not all of them are juicy enough to warrant a post, it’s [...]
Many years ago, I picked up the business section of the Sarasota Herald Tribune, a newspaper that I used to compete against, and saw this headline: “Negative Press Prompts Bank President to Resign”. Apparently, my articles in the Bradenton Herald questioning the accounting techniques at the now-defunct Key Florida Bank were too much for the [...]
RSS
